The present disclosure relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof wherein R1 means a fluorine atom or a perhalogeno linear alkyl radical containing 1, 2 or 3 carbon atoms; R2 means a chlorine atom, a linear alkyl radical containing 1, 2 or 3 carbon atoms or a perhalogeno linear alkyl radical containing 1, 2 or 3 carbon atoms, and R means a hydrogen atom or a radical of formula (Ia). The present disclosure also relates to processes for their preparation as well their therapeutic uses, in particular such as for use in the treatment of malaria.
本公开涉及式 (I) 的化合物或其药学上可接受的盐,其中 R1 指
氟原子或含有 1、2 或 3 个碳原子的全卤代直链烷基;R2 指
氯原子、含有 1、2 或 3 个碳原子的直链烷基或含有 1、2 或 3 个碳原子的全卤代直链烷基,R 指氢原子或式 (Ia) 的基。本公开还涉及其制备工艺及其治疗用途,特别是用于治疗疟疾等。